Point of Care Diagnostics Market Trends

Growth Drivers

• Utilization in improving healthcare outcomes: The efficacy of commodities offered by the market has showcased their capabilities in enhancing clinical efficiency and reducing costs at a large scale over the past years. For instance, a 2022 AHRQ study established the efficacy of POC testing in early interventions in eliminating the need for critical hospital admissions by 22.5%, saving around USD 3.3 billion in the U.S. over 2 years. Similarly, it helped diagnostic laboratories achieve 15.2% faster turnaround times in 2023, according to the FDA. As a result, more medical authorities and organizations are heavily investing in this sector to accommodate such advanced solutions to elevate outcomes in their emergency departments.
• Ongoing tech-based advances in the pipeline: The acceleration in the progress of the market is highly attributable to the integration of technologically advanced features. The efforts and strategic initiatives made by global MedTech giants to develop more scalable and accessible solutions are driving adoption and magnifying the capital influx in this merchandise. For instance, in 2024, Roche, in partnership with 150 clinics in the U.S., gained a 9.1% additional revenue share in this field by deploying its AI-powered Cobas Liat systems. Simultaneously, Abbott captured a large consumer base with 50.1 million annual malaria cases in sub-Saharan Africa with the launch of its FDA-authorized BinaxNOW Malaria test in 2024.

Historical Patient Growth & Market Evolution: Foundation for the Future Point of Care Diagnostics Market Expansion

The market witnessed a transformative phase during the remarkable expansion of the patient pool from 2010 to 1020. Particularly, the impact of the COVID-19 pandemic across the globe significantly amplified the demography, multiplying the demand for rapid test kits. Additionally, the rapidly aging population notably contributed to this escalation, shaping the current wave of POC incorporation in regular and mainstream medical practices. Moreover, the variability and enlarged volume, which followed an 8.1-12.4% range of annual growth rate, of this consumer base pushed companies to adopt a personalized approach, bringing innovations to this field.

Historical Patient Growth (2010-2020)

Feasible Expansion Models Shaping the Point of Care Diagnostics Market

The alignment of global leaders with the current trends and consumer needs in the market is structuring the most effective models of a profitable business for new entrants. Their measurable success across diverse healthcare systems is verifying these methods of commercializing and is inspiring & guiding others to craft a unique pathway for every individual landscape. For instance, between 2022 and 2024, a 12.4% rise in revenue generation was observed due to the formation of strategic alliances with local providers to apply community-based deployment as per the guidelines of the National Health Mission in India. Moreover, there is evidence that tailored implementation strategies can overcome traditional barriers.

POC Market Expansion Feasibility Models (2024–2030)

Challenge

• Data integration and interoperability gaps: According to the Office of the National Coordinator for Health Information Technology, till 2024, more than 30.4% of U.S. patients were not able to operate the transfer of POC data to major EHR systems, such as Epic or Cerner. This lack of user awareness about technology integration caused Siemens an additional expenditure of USD 200.4 million on health IT partnerships in 2024. This showcases the limitations in the eligible consumer base expansion and wide adoption in the point of care diagnostics market. Moreover, the resistance toward new technologies among legacy clinical systems may also hinder growth in this field.